USD 23.02
(-0.26%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.75 USD | -56.25% |
2022 | -0.48 USD | -26.32% |
2021 | -0.38 USD | 13.64% |
2020 | -0.44 USD | -1056.52% |
2019 | 0.05 USD | 141.82% |
2018 | -0.11 USD | -200.0% |
2017 | 0.11 USD | -66.67% |
2016 | 0.33 USD | 135.71% |
2015 | 0.14 USD | -46.15% |
2014 | 0.26 USD | -55.93% |
2013 | 0.59 USD | 103.45% |
2012 | 0.29 USD | 11.54% |
2011 | 0.26 USD | 85.71% |
2010 | 0.14 USD | -54.84% |
2009 | 0.31 USD | -73.04% |
2008 | 1.15 USD | 342.31% |
2007 | 0.26 USD | 1400.0% |
2006 | -0.02 USD | 97.56% |
2005 | -0.82 USD | -1.23% |
2004 | -0.81 USD | 50.61% |
2003 | -1.64 USD | -14.69% |
2002 | -1.43 USD | -391.84% |
2001 | 0.49 USD | 16.67% |
2000 | 0.42 USD | 75.0% |
1999 | 0.24 USD | -33.33% |
1998 | 0.36 USD | 9.09% |
1997 | 0.33 USD | 22.22% |
1996 | 0.27 USD | 80.0% |
1995 | 0.15 USD | 66.67% |
1994 | 0.09 USD | 125.0% |
1993 | 0.04 USD | -42.86% |
1992 | 0.07 USD | 187.5% |
1991 | -0.08 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | 0.18 USD | 285.19% |
2024 Q2 | -0.05 USD | -128.22% |
2023 Q2 | -0.08 USD | 74.85% |
2023 Q4 | -0.10 USD | 59.5% |
2023 FY | - USD | -56.25% |
2023 Q1 | -0.33 USD | -713.38% |
2023 Q3 | -0.24 USD | -189.16% |
2022 FY | - USD | -26.32% |
2022 Q1 | -0.08 USD | 83.33% |
2022 Q2 | -0.11 USD | -29.41% |
2022 Q3 | -0.34 USD | -209.09% |
2022 Q4 | 0.05 USD | 115.82% |
2021 Q1 | -0.08 USD | 10.99% |
2021 Q2 | -0.06 USD | 30.99% |
2021 Q3 | 0.27 USD | 583.01% |
2021 Q4 | -0.51 USD | -288.89% |
2021 FY | - USD | 13.64% |
2020 FY | - USD | -1056.52% |
2020 Q3 | -0.08 USD | 24.3% |
2020 Q1 | -0.18 USD | -883.61% |
2020 Q2 | -0.10 USD | 44.44% |
2020 Q4 | -0.09 USD | -20.21% |
2019 Q2 | 0.08 USD | 1087.65% |
2019 FY | - USD | 141.82% |
2019 Q1 | -0.01 USD | 82.95% |
2019 Q3 | -0.00 USD | -104.5% |
2019 Q4 | -0.02 USD | -408.33% |
2018 Q2 | 0.01 USD | 109.09% |
2018 Q4 | -0.05 USD | -218.75% |
2018 Q3 | 0.04 USD | 300.0% |
2018 FY | - USD | -200.0% |
2018 Q1 | -0.11 USD | -24.43% |
2017 Q4 | -0.09 USD | -321.0% |
2017 Q3 | 0.04 USD | -55.56% |
2017 FY | - USD | -66.67% |
2017 Q2 | 0.09 USD | 28.57% |
2017 Q1 | 0.07 USD | -22.22% |
2016 Q2 | 0.07 USD | -12.5% |
2016 FY | - USD | 135.71% |
2016 Q1 | 0.08 USD | -11.11% |
2016 Q4 | 0.09 USD | 0.0% |
2016 Q3 | 0.09 USD | 28.57% |
2015 Q3 | 0.08 USD | 541.99% |
2015 Q2 | -0.02 USD | -75.73% |
2015 Q4 | 0.09 USD | 12.5% |
2015 FY | - USD | -46.15% |
2015 Q1 | -0.01 USD | -115.85% |
2014 Q4 | 0.06 USD | -18.75% |
2014 Q3 | 0.08 USD | 0.0% |
2014 Q1 | 0.04 USD | -87.88% |
2014 Q2 | 0.08 USD | 100.0% |
2014 FY | - USD | -55.93% |
2013 Q1 | 0.08 USD | 0.0% |
2013 Q2 | 0.06 USD | -25.0% |
2013 FY | - USD | 103.45% |
2013 Q4 | 0.33 USD | 200.0% |
2013 Q3 | 0.11 USD | 83.33% |
2012 Q4 | 0.08 USD | 33.33% |
2012 Q3 | 0.06 USD | -50.0% |
2012 Q2 | 0.12 USD | 200.0% |
2012 Q1 | 0.04 USD | -42.03% |
2012 FY | - USD | 11.54% |
2011 Q1 | 0.06 USD | -22.08% |
2011 Q4 | 0.07 USD | -1.43% |
2011 Q2 | 0.07 USD | 16.67% |
2011 Q3 | 0.07 USD | 0.0% |
2011 FY | - USD | 85.71% |
2010 Q4 | 0.08 USD | 170.0% |
2010 Q1 | 0.07 USD | -16.67% |
2010 Q2 | 0.10 USD | 42.86% |
2010 Q3 | -0.11 USD | -210.0% |
2010 FY | - USD | -54.84% |
2009 Q1 | 0.07 USD | -91.36% |
2009 Q3 | 0.07 USD | -22.22% |
2009 FY | - USD | -73.04% |
2009 Q4 | 0.08 USD | 20.0% |
2009 Q2 | 0.09 USD | 28.57% |
2008 Q3 | 0.13 USD | -7.14% |
2008 Q1 | 0.10 USD | 4.17% |
2008 FY | - USD | 342.31% |
2008 Q2 | 0.14 USD | 40.0% |
2008 Q4 | 0.81 USD | 523.08% |
2007 FY | - USD | 1400.0% |
2007 Q4 | 0.10 USD | 37.14% |
2007 Q3 | 0.07 USD | 40.0% |
2007 Q2 | 0.05 USD | 25.0% |
2007 Q1 | 0.04 USD | 2100.0% |
2006 FY | - USD | 97.56% |
2006 Q4 | -0.00 USD | -102.86% |
2006 Q3 | 0.07 USD | 704.6% |
2006 Q2 | 0.01 USD | 112.1% |
2006 Q1 | -0.07 USD | -156.79% |
2005 FY | - USD | -1.23% |
2005 Q1 | -0.06 USD | 42.1% |
2005 Q3 | -0.13 USD | 78.33% |
2005 Q4 | -0.03 USD | 78.46% |
2005 Q2 | -0.60 USD | -936.27% |
2004 Q4 | -0.10 USD | 61.54% |
2004 Q2 | -0.14 USD | 56.25% |
2004 Q1 | -0.32 USD | 3.03% |
2004 FY | - USD | 50.61% |
2004 Q3 | -0.26 USD | -85.71% |
2003 FY | - USD | -14.69% |
2003 Q4 | -0.33 USD | -37.5% |
2003 Q3 | -0.24 USD | 78.95% |
2003 Q1 | -0.02 USD | 92.38% |
2003 Q2 | -1.14 USD | -5058.37% |
2002 Q4 | -0.29 USD | 71.29% |
2002 Q3 | -1.01 USD | -260.71% |
2002 Q2 | -0.28 USD | -275.0% |
2002 Q1 | 0.16 USD | 110.53% |
2002 FY | - USD | -391.84% |
2001 Q1 | 0.13 USD | 30.0% |
2001 FY | - USD | 16.67% |
2001 Q4 | 0.08 USD | -45.71% |
2001 Q3 | 0.14 USD | 0.0% |
2001 Q2 | 0.14 USD | 7.69% |
2000 FY | - USD | 75.0% |
2000 Q4 | 0.10 USD | -23.08% |
2000 Q1 | 0.09 USD | 573.68% |
2000 Q2 | 0.11 USD | 22.22% |
2000 Q3 | 0.13 USD | 18.18% |
1999 Q2 | 0.09 USD | 33.29% |
1999 Q1 | 0.07 USD | 75.0% |
1999 Q4 | -0.02 USD | -121.11% |
1999 Q3 | 0.09 USD | -3.54% |
1999 FY | - USD | -33.33% |
1998 FY | - USD | 9.09% |
1998 Q1 | 0.08 USD | 95.12% |
1998 Q2 | 0.11 USD | 37.5% |
1998 Q3 | 0.10 USD | -9.09% |
1998 Q4 | 0.04 USD | -60.0% |
1997 Q1 | 0.07 USD | 100.0% |
1997 FY | - USD | 22.22% |
1997 Q3 | 0.10 USD | 25.0% |
1997 Q4 | 0.04 USD | -59.0% |
1997 Q2 | 0.08 USD | 14.29% |
1996 Q4 | 0.04 USD | -61.11% |
1996 Q3 | 0.09 USD | 28.57% |
1996 Q2 | 0.07 USD | 40.0% |
1996 Q1 | 0.05 USD | 35.14% |
1996 FY | - USD | 80.0% |
1995 Q2 | 0.04 USD | 33.33% |
1995 Q3 | 0.05 USD | 25.0% |
1995 Q4 | 0.04 USD | -26.0% |
1995 FY | - USD | 66.67% |
1995 Q1 | 0.03 USD | -21.05% |
1994 Q2 | 0.02 USD | 100.0% |
1994 Q4 | 0.04 USD | 26.67% |
1994 FY | - USD | 125.0% |
1994 Q1 | 0.01 USD | -28.57% |
1994 Q3 | 0.03 USD | 50.0% |
1993 Q2 | 0.01 USD | 0.0% |
1993 FY | - USD | -42.86% |
1993 Q1 | 0.01 USD | 0.0% |
1993 Q3 | 0.01 USD | 0.0% |
1993 Q4 | 0.01 USD | 40.0% |
1992 FY | - USD | 187.5% |
1992 Q1 | -0.01 USD | 0.0% |
1992 Q3 | 0.01 USD | -83.33% |
1992 Q2 | 0.06 USD | 700.0% |
1992 Q4 | 0.01 USD | 0.0% |
1991 Q1 | -0.02 USD | 0.0% |
1991 Q2 | -0.05 USD | -150.0% |
1991 Q3 | -0.01 USD | 80.0% |
1991 Q4 | -0.01 USD | 0.0% |
1991 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Abbott Laboratories | 3.30 USD | 122.727% |
Allurion Technologies Inc. | -2.31 USD | 67.532% |
Avanos Medical, Inc. | -1.33 USD | 43.609% |
Butterfly Network, Inc. | -0.65 USD | -15.385% |
Butterfly Network, Inc. | -0.65 USD | -15.385% |
Bio-Rad Laboratories, Inc. | -21.82 USD | 96.563% |
Boston Scientific Corporation | 1.08 USD | 169.444% |
CONMED Corporation | 2.10 USD | 135.714% |
Edwards Lifesciences Corporation | 2.31 USD | 132.468% |
Paragon 28, Inc. | -0.58 USD | -29.31% |
Glaukos Corporation | -2.78 USD | 73.022% |
Globus Medical, Inc. | 1.09 USD | 168.807% |
Inspire Medical Systems, Inc. | -0.72 USD | -4.167% |
Integer Holdings Corporation | 2.72 USD | 127.574% |
Medtronic plc | 2.77 USD | 127.076% |
Myomo, Inc. | -0.28 USD | -167.857% |
Nevro Corp. | -2.56 USD | 70.703% |
Owlet, Inc. | -4.53 USD | 83.444% |
Penumbra, Inc. | 2.37 USD | 131.646% |
Vicarious Surgical Inc. | -0.49 USD | -53.061% |
Smith & Nephew plc | 0.60 USD | 225.0% |
Sonendo, Inc. | -0.65 USD | -15.385% |
STERIS plc | 3.83 USD | 119.582% |
Stryker Corporation | 8.34 USD | 108.993% |
Vapotherm, Inc. | -9.64 USD | 92.22% |
Zimmer Biomet Holdings, Inc. | 4.91 USD | 115.275% |